Specialty Drugs and Gene Therapies: Driving Value and Mitigating Volatility

Given the rising costs of newer specialty medications and gene therapies, employers would be wise to consider strategies to increase the value of high-cost drugs to best improve health and well-being and to mitigate cost increases to the plan and individual.